The current results demonstrate the expression of BLT2 in all human pancreatic cancer cell lines tested and overexpression in all the human pancreatic tissues obtained from patients with pancreatic adenocarcinoma and chronic pancreatitis, when PanIN lesions are present. This evidence concerns the gene LTB4R2 and chronic pancreatitis.